Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir

Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir

Background/Aims Tenofovir disoproxil fumarate (TDF) monotherapy for 48 weeks provided a virological response comparable to that of TDF and entecavir (ETV) combination therapy in patients infected with ETV-resistant hepatitis B virus (HBV). Little long-term data in routine clinical practice are avail...

Full description

Bibliographic Details
Main Authors: Hee-Jeong Jeon, Seok Won Jung, Neung Hwa Park, Yujin Yang, Jin-Hee Noh, Jae-Sung Ahn, Hyung Rae Kim, Jae Ho Lee, Jung Woo Shin
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2017-09-01
Series:Clinical and Molecular Hepatology
Subjects:
Tenofovir
Resistance
Lamivudine
Entecavir
Chronic hepatitis B
Online Access:http://e-cmh.org/upload/pdf/cmh-2017-0003.pdf

Internet

http://e-cmh.org/upload/pdf/cmh-2017-0003.pdf

Similar Items